Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Phylogenetics and taxonomy of the fungal vascular wilt pathogen Verticillium , with the descriptions of five new species
Oxidative stress: new insights on the association of non-alcoholic fatty liver disease and atherosclerosis
Skin renewal aids in both the removal of dead cells and the promotion of new, underpinning cells to the surface
Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes
10 mg 30 capsules $250 Found in the brain, this peptide can help with pain management, substance withdrawal, and improve sleep stress